NeoGenomics NeoGenomics Laboratories is a provider of oncology diagnostic testing and consultative services. | ![]() Opko Health Opko Health engages in the discovery and development of novel and proprietary technologies for pharmaceuticals and diagnostics. | |
Founding Date | Founding Date 2002 | Founding Date 2007 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Fort Myers, US HQ Suzhou, CN Rolle, CH Aliso Viejo, US Atlanta, US Carlsbad, US Fort Myers, US see more | Locations Miami, US HQ Woburn, US |
Employees | Employees 2,100 | Employees 6,0967% increase |
Valuation ($) | Valuation ($) 1.7 b | Valuation ($) 1.1 b |
Financial | ||
Revenue (est.) | Revenue (est.) $727.3m (FY, 2025) | Revenue (est.) $606.9m (FY, 2025) |
Cost of goods | Cost of goods $413m (FY, 2025) | Cost of goods $400.9m (FY, 2025) |
Gross profit | Gross profit $314.3m (FY, 2025) | Gross profit $205.9m (FY, 2025) |
Net income | Net income ($108m) (FY, 2025) | Net income ($225.7m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 150m | Total funding raised $ 31m |

Opko Health engages in the discovery and development of novel and proprietary technologies for pharmaceuticals and diagnostics.
View company